MedTrace Logo

Diagnostic Reasoning With Customized GPT-4 Model

NCT06911645 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-04-04

No results posted yet for this study

Summary

This study will assess the impact of immediate access to a customized version of GPT-4, a large language model, on performance in case-based diagnostic reasoning tasks. Specifically, it will compare this approach to a two-step process where participants first use traditional diagnostic decision support tools to support their diagnostic reasoning before gaining access to the customized GPT-4 model.

Conditions

  • Pathologic Processes
  • Disease

Interventions

OTHER

Immediate access to customized version of GPT-4

Group is given immediate access to a customized version of GPT-4 to support their diagnostic reasoning for each case.

OTHER

Access to customized version of GPT-4 following use of conventional resources

Group is first encouraged to reason through diagnostic cases with the support of conventional resources. After they submit a case's answers they are then given access to a customized version of GPT-4 and have the opportunity to change their initial answers.

Sponsors & Collaborators

Principal Investigators

  • Jonathan H Chen, MD, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2025-01-24
Completion
2025-01-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06911645 on ClinicalTrials.gov